Breast Cancer Research and Treatment

, Volume 116, Issue 1, pp 125–127 | Cite as

Neuropsychological studies in breast cancer: in search of chemobrain

  • Steven Castellon
  • Patricia A. GanzEmail author
Invited Commentary

Earlier detection and diagnosis of breast cancer has resulted in a growing number of patients with non-invasive tumors or localized invasive breast cancers. Among these early-stage patients, survival rates are high and most women can anticipate a normal life expectancy—making understanding and attending to post-treatment quality of life issues particularly pertinent. One area that has received increasing attention over the last several years is cognitive functioning [1, 2, 3], which is known to be strongly related to quality of life. The focus on post-treatment neurocognitive function has grown out of the recognition that a sizeable minority of patients undergoing adjuvant chemotherapy report and/or demonstrate some degree of cognitive compromise.

In this issue of ‘Breast Cancer Research and Treatment’, Quesnel and colleagues [4], report findings from a longitudinal study of early-stage breast cancer patients, (half of whom received adjuvant chemotherapy in addition to radiotherapy,...


Breast Cancer Breast Cancer Survivor Cancer Group Menopausal Endocrine Therapy Cognitive Complaint 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Supported in part by the Breast Cancer Research Foundation.


  1. 1.
    Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi: 10.1038/nrc2073 PubMedCrossRefGoogle Scholar
  2. 2.
    Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629. doi: 10.1093/annonc/mdm500 PubMedCrossRefGoogle Scholar
  3. 3.
    Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233–2239. doi: 10.1200/JCO.2004.08.094 PubMedCrossRefGoogle Scholar
  4. 4.
    Quesnel C, Savard J, Ivers H (2008) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. doi: 10.1007/s10549-008-0114-2 PubMedGoogle Scholar
  5. 5.
    Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913. doi: 10.1002/cncr.22610 PubMedCrossRefGoogle Scholar
  6. 6.
    Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742–1745PubMedCrossRefGoogle Scholar
  7. 7.
    Schagen SB, Vardy J (2007) Cognitive dysfunction in people with cancer. Lancet Oncol 8:852–853. doi: 10.1016/S1470-2045(07)70287-5 PubMedCrossRefGoogle Scholar
  8. 8.
    Jenkins V, Shilling V, Deutsch G et al (2006) A 3 year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834. doi: 10.1038/sj.bjc.6603029 PubMedCrossRefGoogle Scholar
  9. 9.
    Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New YorkGoogle Scholar
  10. 10.
    Chelune CJ, Naugle RI, Lueders H, Sedlak J, Awad IIA (1993) Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology 7:41–52. doi: 10.1037/0894-4105.7.1.41 CrossRefGoogle Scholar
  11. 11.
    Heaton RK, Temkin N, Dikmen S et al (2001) Detecting change: a comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol 16:75–91. doi: 10.1016/S0887-6177(99)00062-1 PubMedGoogle Scholar
  12. 12.
    Sherwin BB (2003) Estrogen and cognitive functioning in women. Endocr Rev 24:133–151. doi: 10.1210/er.2001-0016 PubMedCrossRefGoogle Scholar
  13. 13.
    Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S (2004) Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61–66. doi: 10.1002/pon.709 PubMedCrossRefGoogle Scholar
  14. 14.
    Castellon SA, Ganz PA, Bower JE, Petersen LA, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969. doi: 10.1080/13803390490510905 PubMedCrossRefGoogle Scholar
  15. 15.
    Silverman DH, Dy CJ, Castellon SA et al (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103:303–311. doi: 10.1007/s10549-006-9380-z PubMedCrossRefGoogle Scholar
  16. 16.
    Saykin AJ, Wishart HA, Rabin LA et al (2006) Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834–842. doi: 10.1212/01.wnl.0000234032.77541.a2 PubMedCrossRefGoogle Scholar
  17. 17.
    Sherwin BB, Henry JF (2008) Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 29:88–113PubMedGoogle Scholar
  18. 18.
    Ferguson RJ, Ahles TA, Saykin AJ et al (2007) Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16:772–777. doi: 10.1002/pon.1133 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  1. 1.Department of Psychiatry and Biobehavioral SciencesDavid Geffen School of Medicine at UCLALos AngelesUSA
  2. 2.Department of Mental Health and PsychiatryWest Los Angeles Veterans Affairs Medical CenterLos AngelesUSA
  3. 3.Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer CenterUCLA Schools of Medicine & Public HealthLos AngelesUSA

Personalised recommendations